Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00333710 · ClinicalTrials.gov registry record · NA

Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT00333710: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00333710 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00333710, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

The main objective of this proposal is to develop and test the efficacy of two interventions (a telehealth and face-to-face intervention) designed to improve quality of life, self-care, motivation to engage in healthcare, and psychological distress in patients diagnosed with HCV and PTSD. It is hypothesized that

Primary Outcome

This is a 62-item measure which assesses knowledge of the hepatitis C Virus. Range is 0 to 62. Higher scores reflect greater hepatitis C knowledge

Interventions

  • BEHAVIORAL Telehealth Intervention
  • BEHAVIORAL Individual psychotherapy

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2006-09
Est. Completion 2009-10
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00333710 record still lists

NCT00333710 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Telehealth Intervention is the first listed.

NCT00333710 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00333710 about?

NCT00333710 is a clinical study titled "Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD". The main objective of this proposal is to develop and test the efficacy of two interventions (a telehealth and face-to-face intervention) designed to improve quality of life, self-care, motivation to engage in healthcare, and psychological distress in patients diagnosed with HCV and PTSD. It is hypo...

What is the current status of trial NCT00333710?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2006-09. Estimated completion is 2009-10.

What interventions are being tested in trial NCT00333710?

The interventions under investigation include: Telehealth Intervention (BEHAVIORAL), Individual psychotherapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00333710?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00333710's enrollment target sits among peer trials

53 1271st of 2000 higher than 729 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00333710, the US trial registry maintained by the National Library of Medicine. NCT00333710 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.